The researchers highlight CO₂ laser excision as a precise, minimally invasive, and effective treatment for large xanthelasma palpebrarum lesions, marking a significant advancement in therapeutic ...

An American man in his early 40s had cholesterol oozing from his blood vessels, a condition that doctors diagnosed as xanthelasma due to a carnivore diet he followed for more than eight months.

Picture: istock. These deposits are commonly found around the eye, a condition called xanthelasma palpebrarum, but can present, as in this case, elsewhere in the body.

Carnivore no more? A Florida man in his mid-40s on a meat, fat, and dairy-heavy diet arrived at a Tampa hospital with ooze emanating from yellowish nodes on the palms of his hands, elbows, and the ...

Such deposits are often seen around the eye (a condition called xanthelasma palpebrarum), which often strikes people with lipid abnormalities, such as familial hypercholesterolemia. It’s thought ...

Xanthelasma—especially xanthelasma palpebrarum—is not always associated with high cholesterol and heart risks, but having high total cholesterol is strongly associated with coronary heart disease.

Xanthelasma, also known as xanthelasma palpebrarum (XP), is a condition where cholesterol builds up under the skin to form soft, yellow growths on or around the eyelids. It's a type of xanthoma ...

Xanthelasma—especially xanthelasma palpebrarum—is not always associated with high cholesterol and heart risks, but having high total cholesterol is strongly associated with coronary heart disease.

If you have an eyelid bump, it might be a stye, chalazion, xanthelasma, or milia. Learn more about the causes, symptoms, treatment, outlook, and prevention of different types of eyelid bumps.

Research has established that xanthelasma palpebrarum (XP), which is associated with yellowish cholesterol deposits on the eyelids, does not significantly contribute to the incidence of dyslipidemia ...

The following is a summary of "Carbon dioxide laser excision as a novel treatment for large xanthelasma palpebrarum: long-term efficacy and safety," published in the September 2024 issue of ...